Synergistic enhancement of immunogenicity and protection in mice against Schistosoma japonicum with codon optimization and electroporation delivery of SjTPI DNA vaccines

Vaccine

Volumn 28, Issue 32, 2010, Pages 5347-5355

  Zhu, Yinchang ^a   Lu, Fei ^a,b   Dai, Yang ^a   Wang, Xiaoting ^a   Tang, Jianxia ^a   Zhao, Song ^a   Zhang, Chun ^a   Zhang, Hui ^a   Lu, Shan ^c,d,e   Wang, Shixia ^d,e  

^a BEIJING HOSPITAL   (China)

^b Yangzhou Polytechnic Institute   (China)

^c Jiangsu Key Laboratory in Infectious Diseases   (China)

^d THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

DNA vaccine; Optimization; Schistosoma japonicum

Indexed keywords

DNA VACCINE; HEAT SHOCK PROTEIN; SCHISTOSOMA JAPONICUM VACCINE; UNCLASSIFIED DRUG; CODON; HELMINTH ANTIBODY; HELMINTH DNA; PARASITE ANTIGEN; TRIOSEPHOSPHATE ISOMERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CODON; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA IMMUNIZATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFICACY; ELECTROPORATION; FEMALE; GENE INSERTION; IMMUNE RESPONSE; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA; TH1 CELL; ANIMAL; BAGG ALBINO MOUSE; BLOOD; ENZYMOLOGY; GENETICS; IMMUNOLOGY; PROCEDURES; VACCINATION;

ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; CODON; DNA, HELMINTH; ELECTROPORATION; FEMALE; MICE; MICE, INBRED BALB C; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA; TRIOSE-PHOSPHATE ISOMERASE; VACCINATION; VACCINES, DNA;

EID: 77954958354     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.05.017     Document Type: Article

References (43)

1. Steinmann P., Keiser J., Bos R., Tanner M., Utzinger J. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. The Lancet Infectious Diseases 2006, 6(July (7)):411-425.
2. McManus D.P., Loukas A. Current status of vaccines for schistosomiasis. Clinical Microbiology Reviews 2008, 21(January (1)):225-242.
3. Ross A.G., Bartley P.B., Sleigh A.C., Olds G.R., Li Y., Williams G.M., et al. Schistosomiasis. The New England Journal of Medicine 2002, 346(April (16)):1212-1220.
4. Gryseels B., Polman K., Clerinx J., Kestens L. Human schistosomiasis. Lancet 2006, 368(September (9541)):1106-1118.
5. Wang L.D., Guo J.G., Wu X.H., Chen H.G., Wang T.P., Zhu S.P., et al. China's new strategy to block Schistosoma japonicum transmission: experiences and impact beyond schistosomiasis. Tropical Medicine and International Health 2009, 14(December (12)):1475-1483.
6. McManus D.P., Bartley P.B. A vaccine against Asian schistosomiasis. Parasitology International 2004, 53(June (2)):163-173.
7. Ross A.G., Sleigh A.C., Li Y., Davis G.M., Williams G.M., Jiang Z., et al. Schistosomiasis in the People's Republic of China: prospects and challenges for the 21st century. Clinical Microbiology Reviews 2001, 14(April (2)):270-295.
8. Steinmann P., Zhou X.N., Matthys B., Li Y.L., Li H.J., Chen S.R., et al. Spatial risk profiling of Schistosoma japonicum in Eryuan county, Yunnan province, China. Geospatial Health 2007, 2(November (1)):59-73.
9. Chen H., Lin D. The prevalence and control of schistosomiasis in Poyang Lake region, China. Parasitology International 2004, 53(June (2)):115-125.
10. Li Y.S., Sleigh A.C., Ross A.G., Williams G.M., Tanner M., McManus D.P. Epidemiology of Schistosoma japonicum in China: morbidity and strategies for control in the Dongting Lake region. International Journal for Parasitology 2000, 30(March (3)):273-281.
11. He Y.X., Salafsky B., Ramaswamy K. Host-parasite relationships of Schistosoma japonicum in mammalian hosts. Trends in Parasitology 2001, 17(July (7)):320-324.
12. Lebens M., Sun J.B., Czerkinsky C., Holmgren J. Current status and future prospects for a vaccine against schistosomiasis. Expert Review of Vaccines 2004, 3(June (3)):315-328.
13. Doenhoff M.J., Pica-Mattoccia L. Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance. Expert Review of Anti-infective Therapy 2006, 4(April (2)):199-210.
14. Wu Z.D., Lu Z.Y., Yu X.B. Development of a vaccine against Schistosoma japonicum in China: a review. Acta Tropica 2005, 96(November-December (2-3)):106-116.
15. McManus D. The Schistosoma japonicum angle on vaccine research. Parasitology Today 2000, 16(August (8)):357-358. [Personal ed.].
16. McManus D.P. A vaccine for schistosomiasis: there is more. Lancet 1995, 346(July (8970)):321-322.
17. McManus D.P. A vaccine against Asian schistosomiasis: the story unfolds. International Journal for Parasitology 2000, 30(March (3)):265-271.
18. LoVerde P.T., Andrade L.F., Oliveira G. Signal transduction regulates schistosome reproductive biology. Current Opinion in Microbiology 2009, 12(August (4)):422-428.
19. Wilson R.A., Coulson P.S. Schistosome vaccines: a critical appraisal. Memorias do Instituto Oswaldo Cruz 2006, 101(September (Suppl. 1)):13-20.
20. Liu S., Song G., Xu Y., Yang W., McManus D.P. Immunization of mice with recombinant Sjc26GST induces a pronounced anti-fecundity effect after experimental infection with Chinese Schistosoma japonicum. Vaccine 1995, 13(April (6)):603-607.
21. Taylor M.G., Huggins M.C., Shi F., Lin J., Tian E., Ye P., et al. Production and testing of Schistosoma japonicum candidate vaccine antigens in the natural ovine host. Vaccine 1998, 16(August (13)):1290-1298.
22. Zhu Y., Si J., Harn D.A., Xu M., Ren J., Yu C., et al. Schistosoma japonicum triose-phosphate isomerase plasmid DNA vaccine protects pigs against challenge infection. Parasitology 2006, 132(January (Pt 1)):67-71.
23. Zhu Y., Si J., Harn D.A., Yu C., Liang Y., Ren J., et al. The protective immunity of a DNA vaccine encoding Schistosoma japonicum Chinese strain triose-phosphate isomerase in infected BALB/C mice. The Southeast Asian Journal of Tropical Medicine and Public Health 2004, 35(September (3)):518-522.
24. Sun W., Liu S., Brindley P.J., McManus D.P. Bacterial expression and characterization of functional recombinant triosephosphate isomerase from Schistosoma japonicum. Protein Expression and Purification 1999, 17(December (3)):410-413.
25. Zhou S., Liu S., Song G., Xu Y., Sun W. Protective immunity induced by the full-length cDNA encoding paramyosin of Chinese Schistosoma japonicum. Vaccine 2000, 18(July (27)):3196-3204.
26. McManus D.P., Liu S., Song G., Xu Y., Wong J.M. The vaccine efficacy of native paramyosin (Sj-97) against Chinese Schistosoma japonicum. International Journal for Parasitology 1998, 28(November (11)):1739-1742.
27. Yuan H., You-En S., Long-Jiang Y., Xiao-Hua Z., Liu-Zhe L., Cash M., et al. Studies on the protective immunity of Schistosoma japonicum bivalent DNA vaccine encoding Sj23 and Sj14. Experimental Parasitology 2007, 115(April (4)):379-386.
28. Zhu Y., Ren J., Harn D.A., Si J., Yu C., Ming X., et al. Protective immunity induced with 23kDa membrane protein DNA vaccine of Schistosoma japonicum Chinese strain in infected C57BL/6 mice. The Southeast Asian Journal of Tropical Medicine and Public Health 2003, 34(December (4)):697-701.
29. Li C., Yu L., Liu Z., Zhu L., Hu Y., Zhu M., et al. Schistosoma japonicum: the design and experimental evaluation of a multivalent DNA vaccine. Cellular and Molecular Biology Letters 2006, 11(4):449-460.
30. Zhu Y., Si J., Ham D.A., Yu C., He W., Hua W., et al. The protective immunity produced in infected C57BL/6 mice of a DNA vaccine encoding Schistosoma japonicum Chinese strain triose-phosphate isomerase. The Southeast Asian Journal of Tropical Medicine and Public Health 2002, 33(June (2)):207-213.
31. Bickle Q.D., Bogh H.O., Johansen M.V., Zhang Y. Comparison of the vaccine efficacy of gamma-irradiated Schistosoma japonicum cercariae with the defined antigen Sj62(IrV-5) in pigs. Veterinary Parasitology 2001, 100(September (1-2)):51-62.
32. Shi Y.E., Jiang C.F., Han J.J., Li Y.L., Ruppel A. Schistosoma japonicum: an ultraviolet-attenuated cercarial vaccine applicable in the field for water buffaloes. Experimental Parasitology 1990, 71(July (1)):100-106.
33. Wang S., Farfan-Arribas D.J., Shen S., Chou T.H., Hirsch A., He F., et al. Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccine. Vaccine 2006, 24(May (21)):4531-4540.
34. Dai Y., Zhu Y., Harn D.A., Wang X., Tang J., Zhao S., et al. DNA vaccination by electroporation and boosting with recombinant proteins enhances efficacy of DNA vaccines for Schistosomiasis japonica. Clinical and Vaccine Immunology 2009, (October).
35. Da'dara A.A., Li Y.S., Xiong T., Zhou J., Williams G.M., McManus D.P., et al. DNA-based vaccines protect against zoonotic schistosomiasis in water buffalo. Vaccine 2008, 26(July (29-30)):3617-3625.
36. Wang S., Zhang C., Zhang L., Li J., Huang Z., Lu S. The relative immunogenicity of DNA vaccines delivered by the intramuscular needle injection, electroporation and gene gun methods. Vaccine 2008, 26(April (17)):2100-2110.
37. Mossadegh N., Gissmann L., Muller M., Zentgraf H., Alonso A., Tomakidi P. Codon optimization of the human papillomavirus 11 (HPV 11) L1 gene leads to increased gene expression and formation of virus-like particles in mammalian epithelial cells. Virology 2004, 326(August (1)):57-66.
38. Ko H.J., Ko S.Y., Kim Y.J., Lee E.G., Cho S.N., Kang C.Y. Optimization of codon usage enhances the immunogenicity of a DNA vaccine encoding mycobacterial antigen Ag85B. Infection and Immunity 2005, 73(September (9)):5666-5674.
39. Hooper J.W., Golden J.W., Ferro A.M., King A.D. Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge. Vaccine 2007, 25(February (10)):1814-1823.
40. Ahlen G., Soderholm J., Tjelle T., Kjeken R., Frelin L., Hoglund U., et al. In vivo electroporation enhances the immunogenicity of hepatitis C virus nonstructural 3/4A DNA by increased local DNA uptake, protein expression, inflammation, and infiltration of CD3+ T cells. Journal of Immunology 2007, 179(October (7)):4741-4753.
41. Luckay A., Sidhu M.K., Kjeken R., Megati S., Chong S.Y., Roopchand V., et al. Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques. Journal of Virology 2007, 81(May (10)):5257-5269.
42. Fuller D.H., Haynes J.R. A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine. AIDS Research and Human Retroviruses 1994, 10(November (11)):1433-1441.
43. Williams G.M., Sleigh A.C., Li Y., Feng Z., Davis G.M., Chen H., et al. Mathematical modelling of Schistosomiasis japonica: comparison of control strategies in the People's Republic of China. Acta Tropica 2002, 82(May (2)):253-262.